These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24911491)

  • 21. How many patents does a biopharmaceutical company need?
    Parida DK; Mehdiratta R; Saberwal G
    Nat Biotechnol; 2008 Jul; 26(7):763-6. PubMed ID: 18612295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biopharmaceutical statistics in a pharmaceutical regulated environment: past, present, and future.
    Segreti AC; Leung HM; Koch GG; Davis RL; Mohberg NR; Peace KE
    J Biopharm Stat; 2001 Nov; 11(4):347-72. PubMed ID: 12018784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent patent applications relating to peptide therapeutics.
    Nat Biotechnol; 2006 Jun; 24(6):656. PubMed ID: 16763592
    [No Abstract]   [Full Text] [Related]  

  • 24. Navigating biotechnology's new fiscal opportunities.
    Purcell DJ
    Nat Biotechnol; 1998 May; 16 Suppl():51-3. PubMed ID: 9591271
    [No Abstract]   [Full Text] [Related]  

  • 25. Patent Watch: Nanomedicine patents highlight importance of production methods.
    Neuman D; Chandhok JN
    Nat Rev Drug Discov; 2016 Jun; 15(7):448-9. PubMed ID: 27357014
    [No Abstract]   [Full Text] [Related]  

  • 26. Biotech patenting upturn.
    Lawrence S
    Nat Biotechnol; 2006 Oct; 24(10):1190. PubMed ID: 17033646
    [No Abstract]   [Full Text] [Related]  

  • 27. (Re)defining biopharmaceutical.
    Rader RA
    Nat Biotechnol; 2008 Jul; 26(7):743-51. PubMed ID: 18612293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Israel: a start-up life science nation.
    Beyar R; Zeevi B; Rechavi G
    Lancet; 2017 Jun; 389(10088):2563-2569. PubMed ID: 28495116
    [No Abstract]   [Full Text] [Related]  

  • 29. [Current service invention patents and growth pathways on basis of cluster analysis].
    Yang XJ; Xiao SY
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(17):2656-60. PubMed ID: 23236772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dusting off outdated patterns.
    Munroe I
    Nature; 2017 Mar; 543(7646):S23-S26. PubMed ID: 28328911
    [No Abstract]   [Full Text] [Related]  

  • 31. With the help of a foreign ally: biopharmaceutical innovation in India after TRIPS.
    Angeli F
    Health Policy Plan; 2014 May; 29(3):280-91. PubMed ID: 23558959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innovator Organizations in New Drug Development: Assessing the Sustainability of the Biopharmaceutical Industry.
    Kinch MS; Moore R
    Cell Chem Biol; 2016 Jun; 23(6):644-53. PubMed ID: 27341432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative Analysis of Technological Innovation in Urology.
    Bhatt NR; Davis NF; Dalton DM; McDermott T; Flynn RJ; Thomas AZ; Manecksha RP
    Urology; 2018 Jan; 111():230-237. PubMed ID: 29024735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Think small! Disruptive science comes from small research teams].
    Haiech J; Jouault T
    Med Sci (Paris); 2020; 36(6-7):651-653. PubMed ID: 32614315
    [No Abstract]   [Full Text] [Related]  

  • 35. IPR and technological issues regarding a biopharmaceutical formulation hemoglobin.
    Honrao C; Banerjee UC; Bansal P
    Recent Pat Biotechnol; 2008; 2(1):60-7. PubMed ID: 19075854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innovation, Royalties, and Introduction of the Patent Hirsch Index within U.S. Academic Neurosurgery.
    Motiwala M; Kumar R; Ajmera S; Lillard J; Saad H; Schultz A; Fraser B; Wallace D; Norrdahl S; Akinduro O; Oravec C; Xu R; Jimenez B; Justo M; Hardee J; Yunis Y; Gungor B; Whitaker J; Klimo P
    World Neurosurg; 2020 May; 137():e395-e405. PubMed ID: 32035202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current Trends in Robotics in Nursing Patents-A Glimpse Into Emerging Innovations.
    Frazier RM; Carter-Templeton H; Wyatt TH; Wu L
    Comput Inform Nurs; 2019 Jun; 37(6):290-297. PubMed ID: 31135470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patent pools and clearinghouses in the life sciences.
    van Zimmeren E; Vanneste S; Matthijs G; Vanhaverbeke W; Van Overwalle G
    Trends Biotechnol; 2011 Nov; 29(11):569-76. PubMed ID: 21733589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The successes and challenges of open-source biopharmaceutical innovation.
    Allarakhia M
    Expert Opin Drug Discov; 2014 May; 9(5):459-65. PubMed ID: 24702304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Determinants of patents in the life sciences and health sciences at federal universities in Minas Gerais State, Brazil: an analysis of panel data for 1995-2016].
    Cóser I; Brandão MAF; Raposo NRB; Gonçalves E
    Cad Saude Publica; 2018 Jun; 34(6):e00097517. PubMed ID: 29952400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.